These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11968790)

  • 21. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of prophylactic vaccines against HIV-1.
    Schiffner T; Sattentau QJ; Dorrell L
    Retrovirology; 2013 Jul; 10():72. PubMed ID: 23866844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in the search for an HIV vaccine.
    Lemckert AA; Goudsmit J; Barouch DH
    Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy.
    Veljkovic V; Metlas R; Köhler H; Urnovitz HB; Prljic J; Veljkovic N; Johnson E; Müller S
    Vaccine; 2001 Feb; 19(15-16):1855-62. PubMed ID: 11228354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Theory for prophylactic AIDS vaccine development].
    Nomura T; Matano T
    Uirusu; 2009 Dec; 59(2):267-75. PubMed ID: 20218335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress with HIV vaccines.
    Biberfeld G; Emini EA
    AIDS; 1991; 5 Suppl 2():S129-33. PubMed ID: 1845044
    [No Abstract]   [Full Text] [Related]  

  • 31. Impending AIDS vaccine trial opens old wounds.
    Balter M
    Science; 1998 Jan; 279(5351):650. PubMed ID: 9471726
    [No Abstract]   [Full Text] [Related]  

  • 32. [Virological and immunological bases for HIV-1 vaccine design].
    Yamamoto H; Matano T
    Uirusu; 2007 Dec; 57(2):133-9. PubMed ID: 18357751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV vaccines: a global perspective.
    Esparza J; Osmanov S
    Curr Mol Med; 2003 May; 3(3):183-93. PubMed ID: 12699356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in HIV vaccine research.
    van der Ryst E
    Oral Dis; 2002; 8 Suppl 2():21-6. PubMed ID: 12164654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thailand weighs AIDS vaccine tests.
    Cohen J
    Science; 1995 Nov; 270(5238):904-7. PubMed ID: 7481784
    [No Abstract]   [Full Text] [Related]  

  • 36. Is there any room for therapeutic vaccination against the HIV-1/AIDS?
    Iglesias E
    Hum Vaccin Immunother; 2013 Jul; 9(7):1539-44. PubMed ID: 23571171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
    Fauci AS; Gallo RC; Koenig S; Salk J; Purcell RH
    Ann Intern Med; 1989 Mar; 110(5):373-85. PubMed ID: 2464961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
    Esparza J; Bhamarapravati N
    Lancet; 2000 Jun; 355(9220):2061-6. PubMed ID: 10885368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospects for an AIDS vaccine: three big questions, no easy answers.
    Garber DA; Silvestri G; Feinberg MB
    Lancet Infect Dis; 2004 Jul; 4(7):397-413. PubMed ID: 15219551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A strategy for prophylactic vaccination against HIV.
    Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
    Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.